» Articles » PMID: 10330191

Protein Kinase B Localization and Activation Differentially Affect S6 Kinase 1 Activity and Eukaryotic Translation Initiation Factor 4E-binding Protein 1 Phosphorylation

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1999 May 18
PMID 10330191
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Recent studies indicate that phosphatidylinositide-3OH kinase (PI3K)-induced S6 kinase (S6K1) activation is mediated by protein kinase B (PKB). Support for this hypothesis has largely relied on results obtained with highly active, constitutively membrane-localized alleles of wild-type PKB, whose activity is independent of PI3K. Here we set out to examine the importance of PKB signaling in S6K1 activation. In parallel, glycogen synthase kinase 3beta (GSK-3beta) inactivation and eukaryotic translation initiation factor 4E-binding protein 1 (4E-BP1) phosphorylation were monitored as markers of the rapamycin-insensitive and -sensitive branches of the PI3K signaling pathway, respectively. The results demonstrate that two activated PKBalpha mutants, whose basal activity is equivalent to that of insulin-induced wild-type PKB, inhibit GSK-3beta to the same extent as a highly active, constitutively membrane-targeted wild-type PKB allele. However, of these two mutants, only the constitutively membrane-targeted allele of PKB induces S6K1 activation. Furthermore, an interfering mutant of PKB, which blocks insulin-induced PKB activation and GSK-3beta inactivation, has no effect on S6K1 activation. Surprisingly, all the activated PKB mutants, regardless of constitutive membrane localization, induce 4E-BP1 phosphorylation and the interfering PKB mutant blocks insulin-induced 4E-BP1 phosphorylation. The results demonstrate that PKB mediates S6K1 activation only as a function of constitutive membrane localization, whereas the activation of PKB appears both necessary and sufficient to induce 4E-BP1 phosphorylation independently of its intracellular location.

Citing Articles

MET receptor serves as a promising target in melanoma brain metastases.

Redmer T, Schumann E, Peters K, Weidemeier M, Nowak S, Schroeder H Acta Neuropathol. 2024; 147(1):44.

PMID: 38386085 PMC: 10884227. DOI: 10.1007/s00401-024-02694-1.


Preclinical evaluation of the CDK4/6 inhibitor palbociclib in combination with a PI3K or MEK inhibitor in colorectal cancer.

Lee C, Cremona M, Farrelly A, Workman J, Kennedy S, Aslam R Cancer Biol Ther. 2023; 24(1):2223388.

PMID: 37326340 PMC: 10281467. DOI: 10.1080/15384047.2023.2223388.


Molecular and therapeutic insights of rapamycin: a multi-faceted drug from Streptomyces hygroscopicus.

Ganesh S, Subathra Devi C Mol Biol Rep. 2023; 50(4):3815-3833.

PMID: 36696023 PMC: 9875782. DOI: 10.1007/s11033-023-08283-x.


Delivery of Active AKT1 to Human Cells.

Siddika T, Balasuriya N, Frederick M, Rozik P, Heinemann I, ODonoghue P Cells. 2022; 11(23).

PMID: 36497091 PMC: 9738475. DOI: 10.3390/cells11233834.


CD133 prevents colon cancer cell death induced by serum deprivation through activation of Akt-mediated protein synthesis and inhibition of apoptosis.

Mori Y, Takeuchi A, Miyagawa K, Yoda H, Soda H, Nabeya Y FEBS Open Bio. 2021; 11(5):1382-1394.

PMID: 33720534 PMC: 8091590. DOI: 10.1002/2211-5463.13145.


References
1.
Pearson R, Dennis P, Han J, Williamson N, Kozma S, Wettenhall R . The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 1995; 14(21):5279-87. PMC: 394637. DOI: 10.1002/j.1460-2075.1995.tb00212.x. View

2.
Pause A, Belsham G, Gingras A, Donze O, Lin T, Lawrence Jr J . Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function. Nature. 1994; 371(6500):762-7. DOI: 10.1038/371762a0. View

3.
Beretta L, Gingras A, Svitkin Y, Hall M, Sonenberg N . Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 1996; 15(3):658-64. PMC: 449984. View

4.
von Manteuffel S, Gingras A, Ming X, Sonenberg N, Thomas G . 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. Proc Natl Acad Sci U S A. 1996; 93(9):4076-80. PMC: 39489. DOI: 10.1073/pnas.93.9.4076. View

5.
Andjelkovic M, Jakubowicz T, Cron P, Ming X, Han J, Hemmings B . Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc Natl Acad Sci U S A. 1996; 93(12):5699-704. PMC: 39123. DOI: 10.1073/pnas.93.12.5699. View